Table 2.
Univariate and multivariable analyses of prognostic factors for 5-year survival in patients with glioma.
| Univariate analysis | Multivariate analysis | |||||||
|---|---|---|---|---|---|---|---|---|
| HR | P > |z| | 95% CI | HR | P > |z| | 95% CI | |||
| KLHDC8A expression | 3.787 | <0.001∗ | 2.684 | 5.344 | 3.028 | <0.001∗ | 2.001 | 4.581 |
| KLHDC8A+CD68+ expression | 2.271 | 0.001∗ | 1.430 | 3.606 | 1.822 | 0.022∗ | 1.090 | 3.044 |
| Sex | ||||||||
| Male vs. female | 1.461 | 0.024∗ | 1.052 | 2.030 | 1.701 | 0.004∗ | 1.188 | 2.433 |
| Age (y) | ||||||||
| ≤60 vs. >60 | 2.098 | <0.001∗ | 1.514 | 2.907 | 1.687 | 0.007∗ | 1.151 | 2.472 |
| Histological classification | ||||||||
| a (AA, AG, AOA, AGG, and PA) vs. b (A) vs. c (GBM) vs. d (MG) vs. e (DA and PPXA) | 1.271 | 0.001∗ | 1.097 | 1.472 | 1.027 | 0.788 | 0.846 | 1.247 |
| IDH1 | ||||||||
| IDH1+ vs. IDH1- | 0.660 | 0.011∗ | 0.479 | 0.910 | 0.653 | 0.018∗ | 0.459 | 0.928 |
| S100A4 | 1.286 | 0.125 | 0.932 | 1.775 | ||||
| CD25 | 1.410 | 0.046∗ | 1.006 | 1.976 | 0.386 | 0.846 | 0.579 | 1.235 |
| Cd66b | 1.289 | 0.133 | 0.925 | 1.795 | ||||
| CD68+CD163+ | 2.170 | <0.001∗ | 1.560 | 3.019 | 1.093 | 0.723 | 0.669 | 1.785 |
| S100A4+CD163+ | 1.728 | 0.001∗ | 1.247 | 2.393 | 0.774 | 0.267 | 0.493 | 1.216 |
| Grade | ||||||||
| I vs. II vs. III vs. IV | 2.284 | <0.001∗ | 1.803 | 2.893 | 1.716 | <0.001∗ | 1.284 | 2.294 |
∗ P < 0.05. a: anaplastic astrocytoma, anaplastic glioma and anaplastic ganglioglioma. b: anaplastic oligoastrocytoma, astrocytoma, diffuse astrocytoma, and oligodendroglioma. c: glioblastoma. d: mixed glioma.